Celery, known scientifically as *Apium graveolens*, belongs to the Apiaceae or Umbelliferae family. This biennial herb has been revered for its medicinal properties and culinary uses for centuries. It grows to a height of 2 to 3 feet, with leaves that arise from the roots and small, fragrant fruits. Let’s explore the morphology, distribution, and […]
Arthritis, a term that encompasses over a hundred different conditions affecting joints and connective tissues, presents a significant health challenge across the globe. Characterized by joint inflammation, commonly referred to as rheumatism, arthritis’s causes range from injury, abnormal metabolism, genetic factors, infections, to an overactive immune system. This comprehensive guide aims to shed light on […]
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to manufacture and market Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg. The approval marks a significant step in expanding the company’s portfolio in the United States pharmaceutical market. Diclofenac Sodium and Misoprostol tablets, generic for […]
Dr. Reddy’s Laboratories, an Indian pharmaceutical company, announced a significant milestone as its tocilizumab biosimilar candidate, DRL_TC, successfully met primary and secondary endpoints in a phase 1 clinical trial. The early-stage study, titled ‘A Phase I, Double Blind, Randomized, Parallel-group, Single dose, Three arm, Comparative Pharmacokinetic and Pharmacodynamic Study of Dr. Reddy’s Laboratories’ Tocilizumab (DRL_TC), […]
Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those affected. However, there are several home remedies that can help manage arthritis and alleviate its symptoms. In this article, we will explore some effective natural remedies for arthritis. Managing your mind as the primary treatment of arthritis […]
American biopharma major Gilead Sciences and immunotherapy company EVOQ Therapeutics have entered into a partnership to develop and market immunotherapy products. Under the collaboration and licensing agreement, Gilead Sciences will acquire the exclusive license for EVOQ Therapeutics’ NanoDisc technology to pursue product candidates for rheumatoid arthritis and lupus treatment. As per the agreement, EVOQ Therapeutics […]
Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis. Lupin said that Rymti is available in Canada as an […]
Strides Pharma Science said that its stepdown fully-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (USFDA) for Cyclosporine Softgel Capsules USP (Modified), 25 mg, 50 mg, and 100 mg. The immunosuppressant medication product is bioequivalent and therapeutically equivalent to Neoral Capsules 25 mg, 50 mg, […]
Lupin Limited said that it has rolled out the authorized generic version of Horizon Medicines’ Duexise (ibuprofen and famotidine) Tablets, 800 mg/26.6 mg. Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg, are used for alleviating signs and symptoms of rheumatoid arthritis and osteoarthritis. The drug is also used for lowering the risk of developing upper gastrointestinal […]
Jyseleca EC approval : Gilead Sciences and Galapagos have secured marketing authorization for Jyseleca (filgotinib 200 mg and 100 mg tablets) from the European Commission (EC) for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults. The approval of the once-daily, oral, JAK1 inhibitor is rheumatoid arthritis patients who showed inadequate response […]